Email Updates

You are here

Home

23 JULY 2021 VOLUME 23 ISSUE 29

Media Coverage

  • Transgender People Face Uphill HIV Prevention Battle

    Transgender people still face significant challenges that prevent them from gaining access to and continuing HIV prevention and care services, despite the disease being first diagnosed 40 years ago.

    July 23, 2021
    General
    Health-E News

  • How Can HIV Research Better Align With the Realities of Transgender and Gender Diverse People?

    Transgender and gender diverse activists and researchers, in partnership with the advocacy organisation AVAC, introduced a powerful manifesto to align HIV prevention research with their current realities and needs, entitled No Data No More at the 11th International AIDS Society Conference on HIV Science (IAS 2021) this week.

    July 22, 2021
    General
    aidsmap

  • Modelling Suggests Injectable Cabotegravir Is Far More Effective Than Daily Oral PrEP for Women

    Cabotegravir injections every other month are a highly effective pre-exposure prophylaxis (PrEP) option for women – and may be even more effective than reported in an earlier analysis, according to research presented this week at the 11th International AIDS Society Conference on HIV Science (IAS 2021).

    July 22, 2021
    PrEP
    aidsmap

  • HIV Prevention: Vaginal Ring Gives Hope to African Women

    With HIV infections posing a significant independent risk factor for both severe illness at hospital admission and in-hospital mortality, according to the World Health Organisation (WHO), the Dapivirine Vaginal Ring promises to offer young women in Africa an additional choice for HIV prevention.

    July 21, 2021
    Microbicides
    Health-E News

  • Screening for Potential PrEP Users at Retail Pharmacies

    Medical counseling remains paramount to offering education to the general public. Long considered one of the most trustworthy in their occupation, pharmacists have a unique opportunity to have health conversations with people and counsel them when appropriate.

    July 21, 2021
    PrEP
    Contagion Live

  • Ending Inequality, Inequity Key to Ending AIDS as a Public Health Threat

    The 2021 UNAIDS Global AIDS Update, launched last week, has rightly pointed out that addressing inequality and inequity are key amongst the issues that need to be urgently addressed over the next decade, which could arguably be the last frontier of the global response to HIV and AIDS.

    July 21, 2021
    Male and Female Condoms, Microbicides, PrEP, Treatment, Voluntary Medical Male Circumcision
    The Herald Zimbabwe

  • Vaginal Ring as Safe as Oral PrEP in Late Pregnancy

    The long-acting dapivirine vaginal ring, which reduces HIV risk in young women, had a comparable safety profile in late pregnancy to an oral daily pre-exposure prophylaxis (PrEP) regimen, according to an interim analysis of a small open-label trial in sub-Saharan Africa.

    July 20, 2021
    Microbicides
    MedPage Today

  • PEPFAR Is Still Without a Leader. HIV Activists Want to Know Why

    The Biden administration has not yet nominated a leader for the President’s Emergency Plan for AIDS Relief, a $7 billion program that sets priorities for AIDS care worldwide — leaving countries that receive funding from the program without guidance during a pandemic that is particularly dire for those with HIV.

    July 20, 2021
    General
    New York Times

  • PrEP, the HIV Prevention Pill, Must Now Be Totally Free Under Almost All Insurance Plans

    In a move that is expected to prove transformative to the national HIV-prevention effort, the federal government has announced that almost all health insurers must cover the HIV prevention pill, known as PrEP, or pre-exposure prophylaxis, with no cost sharing — including for the drug itself and, crucially, for clinic visits and lab tests.

    July 20, 2021
    PrEP
    NBC News

  • IAS: Merck’s Long-Acting HIV Med Hits Protective Levels in Phase 2

    It will be a little while before Merck finds out how well its long-acting HIV drug prevents infection, but in the meantime, the company is revealing phase 2 data—and they’re promising.

    July 20, 2021
    PrEP
    Fierce Biotech

  • An HIV Prevention Manifesto by Transgender and Gender-Diverse People

    Transgender women experience higher rates of HIV than most other populations. Globally, it’s estimated that 19 percent of trans women are living with HIV, 49 times the general population; conversely, not much is known about HIV among transgender men and nonbinary people. Given these facts, why aren’t more transgender and gender-diverse (TGD) people included in HIV-related research and prevention efforts?

    July 19, 2021
    General
    POZ

  • On-Demand PrEP Surpasses Daily Use Among Chinese MSM

    Event-driven HIV prevention regimens appeared to have a better protective effect, and a better trend of medication adherence, than daily regimens in a real-world setting among men who have sex with men (MSM), a researcher said.

    July 19, 2021
    PrEP
    MedPage Today

  • How COVID-19 Changed the Approach to HIV

    As the pandemic spread across the globe, lockdowns and other restrictions designed to curb COVID-19 raised other health risks, particularly in people living with HIV, who feared their access to lifesaving services might be interrupted. Instead, new methods — often designed by patients — of meeting their needs, began cropping up in communities of people living with HIV around the world.

    July 19, 2021
    General, Treatment
    Devex

  • Twice-a-Year Injected Drug Shows Promise for First-Line HIV Treatment

    Early results from a small study suggest that twice-a-year injections of lenacapavir, an experimental HIV capsid inhibitor, can be used as part of a combination regimen for people starting HIV treatment, the 11th International AIDS Society Conference on HIV Science (IAS 2021) heard today.

    July 19, 2021
    Treatment
    aidsmap

  • Kenya: Hope at Last As Distribution of HIV Drugs Begins

    Kenyans who have desperately been waiting for lifesaving antiretroviral drugs can breathe a sigh of relief as distribution began on Wednesday. For eight months, the crucial drugs were stuck at the Mombasa port over a ludicrous distribution row between the Ministry of Health and the United States government that should never have arisen in the first place.

    July 16, 2021
    Treatment
    All Africa

Published Research

Announcements